Literature DB >> 22453174

Insights into the disparate action of osmolytes and macromolecular crowders on amyloid formation.

Shahar Sukenik1, Daniel Harries.   

Abstract

It is widely recognized that amyloid formation sensitively responds to conditions set by myriad cellular solutes. These cosolutes include two important classes: macromolecular crowders and compatible osmolytes. We have recently found that addition of macromolecular PEG only slightly affects fibril formation of a model peptide in vitro. Polyol osmolytes, in contrast, lengthen the lag time for aggregation, and lead to larger fibril mass at equilibrium. To further hypothesize on the molecular underpinnings of the disparate effect of the two cosolute classes, we have further analyzed the experiments using an available kinetic mechanism describing fibril aggregation. Model calculations suggest that all cosolutes similarly lengthen the time required for nucleation, possibly due to their excluded volume effect. However, PEGs may in addition promote fibril fragmentation, leading to lag times that are overall almost unvaried. Moreover, polyols effectively slow the monomer-fibril detachment rates, thereby favoring additional fibril formation. Our analysis provides first hints that cosolutes act not only by changing association or dissociation rates, but potentially also by directing the formation of fibrils of varied morphologies with different mechanical properties. Although additional experiments are needed to unambiguously resolve the action of excluded cosolutes on amyloid formation, it is becoming clear that these compounds are important to consider in the search for ways to modulate fibril formation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22453174      PMCID: PMC3338961          DOI: 10.4161/pri.6.1.18132

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  35 in total

1.  Osmolyte-induced changes in protein conformational equilibria.

Authors:  A J Saunders; P R Davis-Searles; D L Allen; G J Pielak; D A Erie
Journal:  Biopolymers       Date:  2000-04-05       Impact factor: 2.505

2.  Protein-solvent preferential interactions, protein hydration, and the modulation of biochemical reactions by solvent components.

Authors:  Serge N Timasheff
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-03       Impact factor: 11.205

Review 3.  Protein folding and misfolding.

Authors:  Christopher M Dobson
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

Review 4.  Macromolecular crowding: qualitative and semiquantitative successes, quantitative challenges.

Authors:  Damien Hall; Allen P Minton
Journal:  Biochim Biophys Acta       Date:  2003-07-30

5.  Formation of amyloid aggregates from human lysozyme and its disease-associated variants using hydrostatic pressure.

Authors:  Fernanda G De Felice; Marcelo N N Vieira; M Nazareth L Meirelles; Ludmilla A Morozova-Roche; Christopher M Dobson; Sérgio T Ferreira
Journal:  FASEB J       Date:  2004-05-20       Impact factor: 5.191

6.  Macromolecular crowding accelerates amyloid formation by human apolipoprotein C-II.

Authors:  Danny M Hatters; Allen P Minton; Geoffrey J Howlett
Journal:  J Biol Chem       Date:  2001-12-18       Impact factor: 5.157

7.  Living with water stress: evolution of osmolyte systems.

Authors:  P H Yancey; M E Clark; S C Hand; R D Bowlus; G N Somero
Journal:  Science       Date:  1982-09-24       Impact factor: 47.728

Review 8.  Alzheimer's amyloid fibrils: structure and assembly.

Authors:  L C Serpell
Journal:  Biochim Biophys Acta       Date:  2000-07-26

9.  Application of the local-bulk partitioning and competitive binding models to interpret preferential interactions of glycine betaine and urea with protein surface.

Authors:  Daniel J Felitsky; M Thomas Record
Journal:  Biochemistry       Date:  2004-07-20       Impact factor: 3.162

10.  Systematic analysis of nucleation-dependent polymerization reveals new insights into the mechanism of amyloid self-assembly.

Authors:  Wei-Feng Xue; Steve W Homans; Sheena E Radford
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-25       Impact factor: 11.205

View more
  7 in total

1.  Effects of hydrophobic macromolecular crowders on amyloid β (16-22) aggregation.

Authors:  David C Latshaw; Carol K Hall
Journal:  Biophys J       Date:  2015-07-07       Impact factor: 4.033

2.  Critical Influence of Cosolutes and Surfaces on the Assembly of Serpin-Derived Amyloid Fibrils.

Authors:  Michael W Risør; Dennis W Juhl; Morten Bjerring; Joachim Mathiesen; Jan J Enghild; Niels C Nielsen; Daniel E Otzen
Journal:  Biophys J       Date:  2017-08-08       Impact factor: 4.033

3.  Protein fibrillation lag times during kinetic inhibition.

Authors:  Rodrigo S Pagano; Máximo López Medus; Gabriela E Gómez; Paula M Couto; María S Labanda; Lucas Landolfo; Cecilia D'Alessio; Julio J Caramelo
Journal:  Biophys J       Date:  2014-08-05       Impact factor: 4.033

4.  Osmolytes and crowders regulate aggregation of the cancer-related L106R mutant of the Axin protein.

Authors:  Tommaso Garfagnini; Yael Levi-Kalisman; Daniel Harries; Assaf Friedler
Journal:  Biophys J       Date:  2021-06-02       Impact factor: 3.699

5.  Effects of macromolecular crowding on amyloid beta (16-22) aggregation using coarse-grained simulations.

Authors:  David C Latshaw; Mookyung Cheon; Carol K Hall
Journal:  J Phys Chem B       Date:  2014-11-13       Impact factor: 2.991

6.  Polyols (Glycerol and Ethylene glycol) mediated amorphous aggregate inhibition and secondary structure restoration of metalloproteinase-conalbumin (ovotransferrin).

Authors:  Mohsin Vahid Khan; Mohd Ishtikhar; Gulam Rabbani; Masihuz Zaman; Ali Saber Abdelhameed; Rizwan Hasan Khan
Journal:  Int J Biol Macromol       Date:  2016-10-12       Impact factor: 6.953

7.  The effect of chemical chaperones on the assembly and stability of HIV-1 capsid protein.

Authors:  Ayala Lampel; Yaron Bram; Michal Levy-Sakin; Eran Bacharach; Ehud Gazit
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.